Graney & King, LLC
Source: SEC Form 13F · as of Mar 2026Graney & King, LLC holds 21 biotech & pharma companies tracked by BioSniper, totaling $1.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
21
Total value held
$1.3M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 1,601 | $391K |
| LLYELI LILLY & Co | 202 | $186K |
| ABBVAbbVie Inc. | 740 | $161K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 2,465 | $136K |
| GEHCGE HealthCare Technologies Inc. | 865 | $62K |
| MCKMcKesson Corporation | 67 | $58K |
| REGNREGENERON PHARMACEUTICALS, INC. | 69 | $53K |
| AMGNAMGEN INC | 150 | $53K |
| PFEPFIZER INC | 1,845 | $52K |
| BIIBBIOGEN INC. | 106 | $19K |
| RGENREPLIGEN CORP | 160 | $19K |
| PMPhilip Morris International Inc | 101 | $17K |
| GILDGILEAD SCIENCES, INC. | 87 | $12K |
| MEDPMedpace Holdings Inc. | 20 | $10K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 28 | $8K |
| NVONovo Nordisk A/S | 200 | $7K |
| MRKMerck & Co., Inc. | 50 | $6K |
| INCYIncyte Corp. | 50 | $5K |
| VTRSViatris Inc | 176 | $2K |
| OGNOrganon & Co. | 12 | $71 |
| RIOTRiot Platforms, Inc. | 2 | $25 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.